| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.833 | 0.007 | 0.833 | Caspase 9 stimulant | 0.818 0.009 CID_154699486 0.821 0.008 CID_154700038 | ||
| 0.742 | 0.005 | 0.742 | Aldehyde oxidase inhibitor | 0.16 0.13 CID_154699486 | ||
| 0.716 | 0.028 | 0.747 | Apoptosis agonist | 0.747 0.023 CID_154699486 0.744 0.024 CID_154700038 | CID_154699486 | |
| 0.667 | 0.002 | 0.667 | Cystathionine beta-synthase inhibitor | 0.556 0.003 CID_154699486 0.559 0.003 CID_154700038 | ||
| 0.625 | 0.005 | 0.625 | GABA C receptor rho-3 antagonist | |||
| 0.604 | 0.008 | 0.704 | Free radical scavenger | 0.697 0.005 CID_154699486 0.704 0.005 CID_154700038 | CID_154700038 | |
| 0.599 | 0.011 | 0.756 | Antioxidant | 0.743 0.005 CID_154699486 0.756 0.005 CID_154700038 | CID_154700038 | |
| 0.576 | 0.005 | 0.576 | Peroxidase inhibitor | |||
| 0.562 | 0.014 | 0.745 | Histamine release inhibitor | 0.745 0.004 CID_154699486 0.743 0.004 CID_154700038 | CID_154699486 | |
| 0.543 | 0.004 | 0.543 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.526 | 0.006 | 0.526 | Topoisomerase II inhibitor | 0.461 0.008 CID_154699486 0.485 0.007 CID_154700038 | ||
| 0.53 | 0.012 | 0.531 | Hypoxia-inducible factor 1 alpha inhibitor | 0.502 0.014 CID_154699486 0.531 0.012 CID_154700038 | CID_154700038 | |
| 0.548 | 0.032 | 0.548 | 15-Lipoxygenase inhibitor | |||
| 0.495 | 0.005 | 0.495 | Mcl-1 antagonist | |||
| 0.502 | 0.014 | 0.502 | Amyloid beta aggregation inhibitor | 0.283 0.048 CID_154699486 0.258 0.055 CID_154700038 | ||
| 0.506 | 0.03 | 0.618 | 5 Hydroxytryptamine release inhibitor | 0.618 0.009 CID_154699486 0.618 0.009 CID_154700038 | CID_154700038 | |
| 0.485 | 0.021 | 0.485 | Lipoxygenase inhibitor | |||
| 0.468 | 0.005 | 0.468 | DNA intercalator | 0.325 0.01 CID_154699486 0.351 0.009 CID_154700038 | ||
| 0.485 | 0.023 | 0.485 | Caspase 3 stimulant | 0.468 0.025 CID_154699486 0.424 0.037 CID_154700038 | ||
| 0.489 | 0.029 | 0.489 | 5 Hydroxytryptamine release stimulant | 0.254 0.087 CID_154699486 0.37 0.052 CID_154700038 | ||
| 0.462 | 0.004 | 0.512 | Neurotrophic factor enhancer | 0.444 0.005 CID_154699486 0.512 0.004 CID_154700038 | CID_154700038 | |
| 0.478 | 0.024 | 0.478 | 12-Lipoxygenase inhibitor | |||
| 0.472 | 0.024 | 0.472 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.465 | 0.017 | 0.474 | DNA damaging | 0.471 0.017 CID_154699486 0.474 0.016 CID_154700038 | CID_154700038 | |
| 0.452 | 0.019 | 0.452 | Superoxide dismutase inhibitor | |||
| 0.467 | 0.05 | 0.8 | Transcription factor NF kappa B inhibitor | 0.744 0.017 CID_154699486 0.8 0.013 CID_154700038 | CID_154700038 | |
| 0.42 | 0.007 | 0.42 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.31 0.02 CID_154699486 0.366 0.01 CID_154700038 | ||
| 0.408 | 0.004 | 0.408 | Estrogen receptor beta antagonist | 0.094 0.075 CID_154699486 0.098 0.069 CID_154700038 | ||
| 0.435 | 0.032 | 0.435 | Aryl hydrocarbon receptor agonist | 0.156 0.131 CID_154699486 | ||
| 0.409 | 0.005 | 0.409 | 5-Lipoxygenase inhibitor | |||
| 0.413 | 0.015 | 0.617 | Cyclic AMP phosphodiesterase inhibitor | 0.544 0.005 CID_154699486 0.617 0.004 CID_154700038 | CID_154700038 | |
| 0.42 | 0.022 | 0.42 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.405 | 0.013 | 0.405 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.392 | 0.005 | 0.392 | Telomerase inhibitor | 0.083 0.043 CID_154699486 0.072 0.05 CID_154700038 | ||
| 0.39 | 0.004 | 0.39 | HIV-1 integrase (3'-Processing) inhibitor | 0.118 0.02 CID_154699486 0.118 0.02 CID_154700038 | ||
| 0.448 | 0.063 | 0.448 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.386 | 0.005 | 0.386 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.383 | 0.005 | 0.383 | Topoisomerase II alpha inhibitor | 0.339 0.005 CID_154699486 0.35 0.005 CID_154700038 | ||
| 0.398 | 0.019 | 0.398 | Transcription factor STAT inhibitor | |||
| 0.382 | 0.006 | 0.394 | Topoisomerase I inhibitor | 0.394 0.005 CID_154699486 0.392 0.005 CID_154700038 | CID_154699486 | |
| 0.38 | 0.005 | 0.38 | Estrogen antagonist | 0.131 0.037 CID_154699486 0.134 0.033 CID_154700038 | ||
| 0.393 | 0.019 | 0.393 | RNA-directed DNA polymerase inhibitor | 0.294 0.033 CID_154699486 0.301 0.031 CID_154700038 | ||
| 0.38 | 0.009 | 0.506 | NOS3 expression enhancer | 0.506 0.005 CID_154699486 0.441 0.006 CID_154700038 | CID_154699486 | |
| 0.374 | 0.004 | 0.374 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.02 CID_154699486 0.116 0.017 CID_154700038 | ||
| 0.373 | 0.005 | 0.373 | Dopamine agonist | 0.057 0.055 CID_154699486 | ||
| 0.388 | 0.021 | 0.388 | Transcription factor STAT3 inhibitor | 0.188 0.151 CID_154699486 0.193 0.144 CID_154700038 | ||
| 0.393 | 0.027 | 0.393 | Dyrk kinase inhibitor | |||
| 0.426 | 0.065 | 0.426 | Calcium channel L-type activator | |||
| 0.381 | 0.025 | 0.381 | Pyruvate kinase inhibitor | |||
| 0.369 | 0.013 | 0.369 | Tubulin antagonist | |||
| 0.363 | 0.019 | 0.363 | Dual specificity phosphatase inhibitor | |||
| 0.408 | 0.065 | 0.408 | Prostaglandin dehydrogenase inhibitor | |||
| 0.375 | 0.035 | 0.375 | Calcium channel activator | |||
| 0.347 | 0.013 | 0.347 | Protein-tyrosine phosphatase inhibitor | 0.225 0.038 CID_154699486 0.244 0.032 CID_154700038 | ||
| 0.401 | 0.076 | 0.697 | Antibacterial | 0.697 0.009 CID_154699486 0.696 0.009 CID_154700038 | CID_154699486 | |
| 0.325 | 0.004 | 0.325 | Creatine kinase inhibitor | 0.109 0.051 CID_154699486 0.084 0.08 CID_154700038 | ||
| 0.435 | 0.118 | 0.815 | Antiinflammatory | 0.815 0.013 CID_154699486 0.812 0.014 CID_154700038 | CID_154699486 | |
| 0.32 | 0.005 | 0.32 | Estrogen receptor alpha antagonist | |||
| 0.319 | 0.004 | 0.319 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 CID_154699486 | ||
| 0.313 | 0.009 | 0.313 | Heat shock protein 90 antagonist | 0.139 0.086 CID_154700038 | ||
| 0.325 | 0.024 | 0.325 | Dual specificity phosphatase 3 inhibitor | |||
| 0.303 | 0.01 | 0.303 | Chelator | 0.093 0.088 CID_154699486 0.103 0.073 CID_154700038 | ||
| 0.297 | 0.005 | 0.297 | Mannose-6-phosphate isomerase inhibitor | 0.274 0.008 CID_154699486 0.277 0.007 CID_154700038 | ||
| 0.313 | 0.022 | 0.313 | Protein kinase C nu inhibitor | |||
| 0.292 | 0.005 | 0.292 | Estrogen agonist | 0.134 0.012 CID_154699486 0.154 0.011 CID_154700038 | ||
| 0.289 | 0.004 | 0.289 | CDC25A inhibitor | 0.079 0.045 CID_154699486 0.103 0.026 CID_154700038 | ||
| 0.298 | 0.015 | 0.298 | Heat shock protein 90 alpha antagonist | |||
| 0.307 | 0.024 | 0.481 | DNA methyltransferase I inhibitor | 0.401 0.009 CID_154699486 0.481 0.005 CID_154700038 | CID_154700038 | |
| 0.347 | 0.066 | 0.639 | Cholesterol antagonist | 0.639 0.014 CID_154699486 0.606 0.018 CID_154700038 | CID_154699486 | |
| 0.325 | 0.045 | 0.423 | Antiamyloidogenic | 0.404 0.028 CID_154699486 0.423 0.025 CID_154700038 | CID_154700038 | |
| 0.291 | 0.014 | 0.291 | NADPH oxidase inhibitor | 0.234 0.025 CID_154699486 0.264 0.018 CID_154700038 | ||
| 0.289 | 0.012 | 0.289 | Succinate dehydrogenase inhibitor | 0.149 0.115 CID_154699486 | ||
| 0.278 | 0.004 | 0.278 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.294 | 0.023 | 0.533 | Melanin inhibitor | 0.533 0.005 CID_154699486 0.465 0.008 CID_154700038 | CID_154699486 | |
| 0.277 | 0.007 | 0.277 | Catenin beta inhibitor | 0.153 0.099 CID_154700038 | ||
| 0.274 | 0.006 | 0.274 | Protein kinase C zeta inhibitor | |||
| 0.353 | 0.085 | 0.568 | Immunosuppressant | 0.568 0.017 CID_154699486 0.546 0.022 CID_154700038 | CID_154699486 | |
| 0.285 | 0.018 | 0.442 | Alpha-N-acetylglucosaminidase inhibitor | 0.442 0.007 CID_154699486 0.442 0.007 CID_154700038 | CID_154700038 | |
| 0.315 | 0.05 | 0.315 | Insulysin inhibitor | |||
| 0.268 | 0.01 | 0.465 | ATPase inhibitor | 0.465 0.003 CID_154699486 0.414 0.003 CID_154700038 | CID_154699486 | |
| 0.299 | 0.041 | 0.554 | Nitric oxide antagonist | 0.554 0.012 CID_154699486 0.524 0.014 CID_154700038 | CID_154699486 | |
| 0.262 | 0.005 | 0.262 | Dopamine D2 agonist | 0.104 0.01 CID_154699486 0.069 0.018 CID_154700038 | ||
| 0.299 | 0.044 | 0.484 | DNA synthesis inhibitor | 0.454 0.017 CID_154699486 0.484 0.015 CID_154700038 | CID_154700038 | |
| 0.377 | 0.124 | 0.693 | Alpha-glucosidase inhibitor | 0.693 0.035 CID_154699486 0.674 0.039 CID_154700038 | CID_154699486 | |
| 0.284 | 0.033 | 0.475 | DNA methylase inhibitor | 0.398 0.011 CID_154699486 0.475 0.007 CID_154700038 | CID_154700038 | |
| 0.261 | 0.01 | 0.261 | GABA C receptor rho-2 antagonist | |||
| 0.256 | 0.005 | 0.256 | MAP3K9 inhibitor | 0.125 0.104 CID_154699486 0.125 0.104 CID_154700038 | ||
| 0.253 | 0.004 | 0.253 | CDC25B inhibitor | 0.066 0.042 CID_154700038 | ||
| 0.252 | 0.004 | 0.252 | CD45 antagonist | 0.046 0.045 CID_154699486 | ||
| 0.26 | 0.015 | 0.427 | Hexokinase inhibitor | 0.427 0.004 CID_154699486 0.416 0.004 CID_154700038 | CID_154699486 | |
| 0.257 | 0.016 | 0.257 | DNA polymerase I inhibitor | 0.246 0.018 CID_154699486 0.211 0.025 CID_154700038 | ||
| 0.242 | 0.006 | 0.242 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.076 0.055 CID_154699486 | ||
| 0.238 | 0.004 | 0.238 | HIV-1 integrase inhibitor | 0.094 0.028 CID_154699486 0.094 0.029 CID_154700038 | ||
| 0.26 | 0.025 | 0.6 | Amylase inhibitor | 0.519 0.005 CID_154699486 0.6 0.004 CID_154700038 | CID_154700038 | |
| 0.268 | 0.036 | 0.58 | Non-steroidal antiinflammatory agent | 0.466 0.008 CID_154699486 0.58 0.005 CID_154700038 | CID_154700038 | |
| 0.253 | 0.024 | 0.253 | Phospholipase C inhibitor | 0.209 0.038 CID_154699486 0.186 0.055 CID_154700038 | ||
| 0.235 | 0.008 | 0.235 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.25 | 0.024 | 0.564 | Monophenol monooxygenase inhibitor | 0.521 0.007 CID_154699486 0.564 0.006 CID_154700038 | CID_154700038 | |
| 0.233 | 0.011 | 0.233 | Carbonic anhydrase III inhibitor | 0.132 0.037 CID_154699486 0.13 0.038 CID_154700038 | ||
| 0.236 | 0.014 | 0.401 | Xanthine oxidase inhibitor | 0.325 0.006 CID_154699486 0.401 0.004 CID_154700038 | CID_154700038 | |
| 0.226 | 0.004 | 0.226 | DOPA decarboxylase inhibitor | |||
| 0.229 | 0.009 | 0.229 | Protein kinase C gamma inhibitor | 0.101 0.075 CID_154700038 | ||
| 0.235 | 0.015 | 0.235 | GABA C receptor agonist | |||
| 0.245 | 0.028 | 0.367 | Lipid peroxidase inhibitor | 0.367 0.012 CID_154699486 0.359 0.012 CID_154700038 | CID_154699486 | |
| 0.298 | 0.081 | 0.298 | Sodium/bile acid cotransporter inhibitor | 0.212 0.172 CID_154699486 0.212 0.172 CID_154700038 | ||
| 0.249 | 0.035 | 0.249 | Insulin sensitizer | 0.206 0.068 CID_154699486 0.216 0.058 CID_154700038 | ||
| 0.271 | 0.059 | 0.429 | Vasodilator | 0.381 0.027 CID_154699486 0.429 0.019 CID_154700038 | CID_154700038 | |
| 0.217 | 0.006 | 0.217 | Prolactin inhibitor | |||
| 0.286 | 0.075 | 0.426 | Spasmolytic | 0.389 0.042 CID_154699486 0.426 0.035 CID_154700038 | CID_154700038 | |
| 0.231 | 0.021 | 0.262 | Aldehyde dehydrogenase inhibitor | 0.262 0.016 CID_154699486 0.262 0.016 CID_154700038 | CID_154700038 | |
| 0.297 | 0.088 | 0.537 | Apoptosis antagonist | 0.533 0.016 CID_154699486 0.537 0.016 CID_154700038 | CID_154700038 | |
| 0.224 | 0.015 | 0.224 | Toll-Like receptor 2 antagonist | |||
| 0.244 | 0.035 | 0.244 | Amyloid beta precursor protein antagonist | |||
| 0.273 | 0.064 | 0.625 | Tumour necrosis factor alpha release inhibitor | 0.625 0.006 CID_154699486 0.622 0.006 CID_154700038 | CID_154699486 | |
| 0.219 | 0.01 | 0.23 | Alcohol dehydrogenase inhibitor | 0.23 0.009 CID_154699486 0.189 0.014 CID_154700038 | CID_154699486 | |
| 0.244 | 0.037 | 0.268 | Nitric-oxide synthase stimulant | 0.268 0.022 CID_154699486 0.242 0.038 CID_154700038 | CID_154699486 | |
| 0.297 | 0.09 | 0.46 | Vasodilator, coronary | 0.456 0.022 CID_154699486 0.46 0.022 CID_154700038 | CID_154700038 | |
| 0.302 | 0.096 | 0.316 | Vasodilator, peripheral | 0.316 0.089 CID_154699486 0.306 0.094 CID_154700038 | CID_154699486 | |
| 0.226 | 0.022 | 0.226 | Protein-tyrosine phosphatase 1B inhibitor | 0.197 0.03 CID_154699486 0.198 0.03 CID_154700038 | ||
| 0.208 | 0.007 | 0.208 | Beta tubulin antagonist | |||
| 0.28 | 0.08 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.211 | 0.011 | 0.211 | Porphobilinogen synthase inhibitor | |||
| 0.224 | 0.025 | 0.224 | MAO A inhibitor | |||
| 0.206 | 0.007 | 0.206 | T cell inhibitor | 0.146 0.01 CID_154699486 0.161 0.009 CID_154700038 | ||
| 0.21 | 0.011 | 0.317 | Photosensitizer | 0.317 0.004 CID_154699486 0.317 0.004 CID_154700038 | CID_154700038 | |
| 0.229 | 0.037 | 0.229 | Histone acetyltransferase inhibitor | |||
| 0.205 | 0.012 | 0.63 | Beta glucuronidase inhibitor | 0.553 0.003 CID_154699486 0.63 0.003 CID_154700038 | CID_154700038 | |
| 0.196 | 0.004 | 0.196 | Topoisomerase II beta inhibitor | 0.134 0.005 CID_154699486 0.135 0.005 CID_154700038 | ||
| 0.262 | 0.07 | 0.401 | Interleukin agonist | 0.401 0.019 CID_154699486 0.356 0.027 CID_154700038 | CID_154699486 | |
| 0.238 | 0.047 | 0.551 | Hepatoprotectant | 0.52 0.006 CID_154699486 0.551 0.005 CID_154700038 | CID_154700038 | |
| 0.213 | 0.023 | 0.416 | Alkylator | 0.363 0.009 CID_154699486 0.416 0.007 CID_154700038 | CID_154700038 | |
| 0.212 | 0.023 | 0.212 | Arachidonic acid antagonist | 0.151 0.087 CID_154699486 0.137 0.104 CID_154700038 | ||
| 0.243 | 0.055 | 0.243 | Death-associated protein kinase 3 inhibitor | |||
| 0.255 | 0.074 | 0.691 | Hypoglycemic | 0.691 0.005 CID_154699486 0.691 0.005 CID_154700038 | CID_154700038 | |
| 0.206 | 0.025 | 0.206 | Adenylate cyclase inhibitor | 0.16 0.039 CID_154699486 0.124 0.064 CID_154700038 | ||
| 0.209 | 0.028 | 0.209 | Toll-Like receptor antagonist | |||
| 0.195 | 0.016 | 0.195 | Adenylate cyclase stimulant | 0.152 0.059 CID_154699486 0.135 0.092 CID_154700038 | ||
| 0.193 | 0.014 | 0.193 | GABA C receptor antagonist | |||
| 0.234 | 0.057 | 0.234 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.193 | 0.016 | 0.193 | MAP kinase kinase 4 inhibitor | |||
| 0.181 | 0.005 | 0.181 | Estrogen receptor alpha agonist | |||
| 0.182 | 0.007 | 0.182 | Alpha tubulin antagonist | |||
| 0.177 | 0.005 | 0.177 | Estrogen receptor beta agonist | 0.098 0.012 CID_154699486 0.087 0.013 CID_154700038 | ||
| 0.19 | 0.019 | 0.402 | UDP-glucose 4-epimerase inhibitor | 0.402 0.005 CID_154699486 0.402 0.005 CID_154700038 | CID_154700038 | |
| 0.208 | 0.038 | 0.393 | Interferon gamma antagonist | 0.342 0.015 CID_154699486 0.393 0.011 CID_154700038 | CID_154700038 | |
| 0.235 | 0.066 | 0.235 | Antimitotic | |||
| 0.183 | 0.015 | 0.183 | Protein kinase C mu inhibitor | |||
| 0.182 | 0.014 | 0.505 | AMP-activated protein kinase stimulant | 0.428 0.004 CID_154699486 0.505 0.003 CID_154700038 | CID_154700038 | |
| 0.179 | 0.012 | 0.179 | GABA C receptor rho-1 antagonist | |||
| 0.226 | 0.061 | 0.263 | Anesthetic general | 0.236 0.057 CID_154699486 0.263 0.045 CID_154700038 | CID_154700038 | |
| 0.192 | 0.027 | 0.192 | CF transmembrane conductance regulator agonist | 0.145 0.084 CID_154699486 0.145 0.084 CID_154700038 | ||
| 0.174 | 0.01 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.17 0.013 CID_154699486 0.17 0.013 CID_154700038 | ||
| 0.171 | 0.006 | 0.193 | Glutamate release inhibitor | 0.193 0.005 CID_154699486 0.193 0.005 CID_154700038 | CID_154700038 | |
| 0.172 | 0.008 | 0.172 | Alcohol oxidase inhibitor | |||
| 0.211 | 0.047 | 0.211 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.167 | 0.005 | 0.167 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.173 | 0.012 | 0.173 | Dopamine D1 antagonist | |||
| 0.17 | 0.01 | 0.17 | Glutamate decarboxylase inhibitor | |||
| 0.164 | 0.009 | 0.167 | Aldose reductase inhibitor | 0.135 0.012 CID_154699486 0.167 0.009 CID_154700038 | CID_154700038 | |
| 0.158 | 0.004 | 0.158 | Catechol O-methyltransferase inhibitor | |||
| 0.171 | 0.017 | 0.343 | DNA repair enzyme inhibitor | 0.343 0.004 CID_154699486 0.34 0.004 CID_154700038 | CID_154699486 | |
| 0.169 | 0.018 | 0.189 | Heat shock protein 70 antagonist | 0.189 0.009 CID_154699486 0.169 0.018 CID_154700038 | CID_154699486 | |
| 0.153 | 0.003 | 0.153 | Dopamine D5 agonist | |||
| 0.155 | 0.005 | 0.155 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.194 | 0.044 | 0.242 | Interleukin 6 antagonist | 0.213 0.034 CID_154699486 0.242 0.025 CID_154700038 | CID_154700038 | |
| 0.19 | 0.041 | 0.19 | Neurotensin receptor agonist | |||
| 0.167 | 0.019 | 0.198 | Uric acid excretion stimulant | 0.198 0.013 CID_154699486 0.187 0.015 CID_154700038 | CID_154699486 | |
| 0.191 | 0.043 | 0.191 | MAO inhibitor | |||
| 0.152 | 0.008 | 0.152 | GABA aminotransferase inhibitor | 0.119 0.017 CID_154699486 0.128 0.013 CID_154700038 | ||
| 0.149 | 0.005 | 0.149 | Heat shock protein 90 beta antagonist | |||
| 0.168 | 0.025 | 0.168 | Carbonic anhydrase XV inhibitor | |||
| 0.171 | 0.032 | 0.171 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.233 | 0.094 | 0.233 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.145 | 0.006 | 0.145 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.162 | 0.024 | 0.519 | Mediator release inhibitor | 0.519 0.004 CID_154699486 0.454 0.004 CID_154700038 | CID_154699486 | |
| 0.185 | 0.047 | 0.367 | Protein kinase stimulant | 0.367 0.01 CID_154699486 0.345 0.012 CID_154700038 | CID_154699486 | |
| 0.179 | 0.042 | 0.179 | Bone formation stimulant | 0.116 0.089 CID_154699486 0.135 0.072 CID_154700038 | ||
| 0.144 | 0.006 | 0.144 | D-Ala-D-Ala ligase inhibitor | |||
| 0.155 | 0.019 | 0.155 | Histidine decarboxylase inhibitor | |||
| 0.171 | 0.035 | 0.171 | Cholesterol synthesis inhibitor | 0.133 0.055 CID_154699486 0.111 0.074 CID_154700038 | ||
| 0.165 | 0.03 | 0.512 | Expectorant | 0.445 0.004 CID_154699486 0.512 0.004 CID_154700038 | CID_154700038 | |
| 0.235 | 0.103 | 0.517 | Immunostimulant | 0.513 0.027 CID_154699486 0.517 0.027 CID_154700038 | CID_154700038 | |
| 0.254 | 0.123 | 0.671 | Antithrombotic | 0.641 0.012 CID_154699486 0.671 0.01 CID_154700038 | CID_154700038 | |
| 0.136 | 0.005 | 0.136 | Fatty acid synthase inhibitor | 0.061 0.034 CID_154699486 0.071 0.025 CID_154700038 | ||
| 0.149 | 0.018 | 0.149 | Anabolic | 0.095 0.07 CID_154700038 | ||
| 0.151 | 0.02 | 0.151 | Carbonic anhydrase VI inhibitor | 0.075 0.064 CID_154699486 0.072 0.069 CID_154700038 | ||
| 0.133 | 0.004 | 0.133 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.135 | 0.007 | 0.135 | Dopamine D5 antagonist | |||
| 0.185 | 0.057 | 0.185 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.238 | 0.111 | 0.238 | Streptokinase A inhibitor | |||
| 0.148 | 0.021 | 0.28 | Triose-phosphate isomerase inhibitor | 0.28 0.005 CID_154699486 0.28 0.005 CID_154700038 | CID_154700038 | |
| 0.144 | 0.017 | 0.144 | Macrophage migration inhibitory factor inhibitor | |||
| 0.137 | 0.011 | 0.152 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 CID_154699486 0.147 0.008 CID_154700038 | CID_154699486 | |
| 0.134 | 0.009 | 0.134 | Xanthine dehydrogenase inhibitor | 0.068 0.032 CID_154699486 0.064 0.036 CID_154700038 | ||
| 0.141 | 0.02 | 0.269 | NADH dehydrogenase inhibitor | 0.269 0.007 CID_154699486 0.269 0.007 CID_154700038 | CID_154700038 | |
| 0.16 | 0.04 | 0.429 | Cyclooxygenase 3 inhibitor | 0.429 0.004 CID_154699486 0.37 0.004 CID_154700038 | CID_154699486 | |
| 0.169 | 0.049 | 0.464 | Hemostatic | 0.452 0.005 CID_154699486 0.464 0.005 CID_154700038 | CID_154700038 | |
| 0.152 | 0.034 | 0.152 | 5 Hydroxytryptamine 3A agonist | |||
| 0.173 | 0.055 | 0.173 | Cyclooxygenase inhibitor | 0.147 0.072 CID_154699486 0.112 0.109 CID_154700038 | ||
| 0.14 | 0.024 | 0.199 | Carbonic anhydrase XIII inhibitor | 0.169 0.018 CID_154699486 0.199 0.014 CID_154700038 | CID_154700038 | |
| 0.156 | 0.041 | 0.156 | Antibacterial (Helicobacter pylori) | |||
| 0.143 | 0.03 | 0.143 | Potassium channel (Ca-activated) activator | |||
| 0.139 | 0.026 | 0.139 | Protein kinase C delta inhibitor | |||
| 0.12 | 0.008 | 0.12 | GABA B receptor agonist | |||
| 0.141 | 0.029 | 0.189 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.189 0.018 CID_154699486 0.189 0.018 CID_154700038 | CID_154700038 | |
| 0.164 | 0.053 | 0.335 | Cell wall synthesis inhibitor | 0.335 0.008 CID_154699486 0.311 0.009 CID_154700038 | CID_154699486 | |
| 0.147 | 0.037 | 0.147 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.146 | 0.037 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.143 | 0.034 | 0.168 | CC chemokine 6 receptor antagonist | 0.168 0.009 CID_154699486 0.168 0.009 CID_154700038 | CID_154700038 | |
| 0.13 | 0.023 | 0.13 | CYP2A6 inhibitor | |||
| 0.109 | 0.003 | 0.109 | Dopamine D1 agonist | 0.068 0.004 CID_154699486 0.052 0.004 CID_154700038 | ||
| 0.145 | 0.041 | 0.145 | Alpha 2b adrenoreceptor antagonist | |||
| 0.144 | 0.04 | 0.144 | Ferrochelatase inhibitor | |||
| 0.119 | 0.017 | 0.119 | Thioredoxin reductase inhibitor | |||
| 0.142 | 0.042 | 0.181 | Microtubule formation inhibitor | 0.181 0.025 CID_154699486 0.171 0.028 CID_154700038 | CID_154699486 | |
| 0.118 | 0.018 | 0.118 | Leukotriene synthesis inhibitor | |||
| 0.133 | 0.033 | 0.133 | Antineoplastic alkaloid | |||
| 0.133 | 0.033 | 0.133 | Sphingomyelinase inhibitor | 0.104 0.055 CID_154699486 0.127 0.036 CID_154700038 | ||
| 0.194 | 0.095 | 0.194 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.184 | 0.085 | 0.184 | I kappa B kinase epsilon inhibitor | |||
| 0.113 | 0.014 | 0.113 | Protein kinase C eta inhibitor | 0.054 0.039 CID_154700038 | ||
| 0.179 | 0.08 | 0.189 | P-glycoprotein inhibitor | 0.159 0.103 CID_154699486 0.189 0.072 CID_154700038 | CID_154700038 | |
| 0.125 | 0.027 | 0.125 | Histamine N-methyltransferase inhibitor | |||
| 0.124 | 0.026 | 0.124 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.132 | 0.034 | 0.132 | Urease inhibitor | |||
| 0.132 | 0.035 | 0.132 | Adenylate kinase inhibitor | 0.1 0.067 CID_154699486 0.1 0.067 CID_154700038 | ||
| 0.15 | 0.053 | 0.15 | Cyclooxygenase 2 inhibitor | 0.127 0.072 CID_154699486 | ||
| 0.111 | 0.014 | 0.111 | Estrogen-related receptor beta agonist | |||
| 0.151 | 0.056 | 0.151 | Cyclooxygenase 1 inhibitor | 0.143 0.061 CID_154699486 | ||
| 0.107 | 0.011 | 0.107 | Protein kinase C beta inhibitor | |||
| 0.1 | 0.004 | 0.1 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.108 | 0.014 | 0.115 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.115 0.013 CID_154699486 0.087 0.021 CID_154700038 | CID_154699486 | |
| 0.135 | 0.042 | 0.161 | Mucolytic | 0.161 0.026 CID_154699486 0.159 0.027 CID_154700038 | CID_154699486 | |
| 0.15 | 0.06 | 0.188 | Alkaline phosphatase inhibitor | 0.188 0.038 CID_154699486 0.142 0.065 CID_154700038 | CID_154699486 | |
| 0.127 | 0.037 | 0.303 | Antineoplastic antibiotic | 0.29 0.01 CID_154699486 0.303 0.009 CID_154700038 | CID_154700038 | |
| 0.152 | 0.062 | 0.152 | Toll-Like receptor 9 antagonist | |||
| 0.135 | 0.045 | 0.135 | Interleukin 8 antagonist | |||
| 0.139 | 0.049 | 0.139 | Protein kinase (CK2) alpha inhibitor | |||
| 0.105 | 0.015 | 0.105 | Purinergic P2X1 antagonist | 0.058 0.047 CID_154699486 0.058 0.047 CID_154700038 | ||
| 0.146 | 0.057 | 0.146 | Acetylcholinesterase inhibitor | |||
| 0.144 | 0.055 | 0.167 | Interleukin 4 antagonist | 0.167 0.037 CID_154699486 0.136 0.065 CID_154700038 | CID_154699486 | |
| 0.131 | 0.043 | 0.131 | Transcription factor STAT6 inhibitor | |||
| 0.121 | 0.034 | 0.121 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.107 | 0.02 | 0.107 | Aromatase inhibitor | |||
| 0.176 | 0.091 | 0.176 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.11 | 0.025 | 0.11 | Keratolytic | |||
| 0.112 | 0.028 | 0.112 | Glutathione S-transferase inhibitor | |||
| 0.144 | 0.061 | 0.144 | Nav1.6 sodium channel blocker | |||
| 0.111 | 0.028 | 0.216 | Phosphofructokinase-1 inhibitor | 0.216 0.01 CID_154699486 0.216 0.01 CID_154700038 | CID_154700038 | |
| 0.137 | 0.054 | 0.137 | Vanilloid 1 agonist | 0.137 0.054 CID_154699486 0.121 0.085 CID_154700038 | ||
| 0.111 | 0.029 | 0.111 | Bromodomain-containing protein 2 inhibitor | |||
| 0.097 | 0.016 | 0.097 | MAP kinase kinase 7 inhibitor | |||
| 0.165 | 0.084 | 0.165 | LIM domain kinase 1 inhibitor | |||
| 0.115 | 0.034 | 0.115 | Catalase inhibitor | |||
| 0.144 | 0.064 | 0.144 | Pregnane X receptor agonist | |||
| 0.262 | 0.184 | 0.262 | DNA directed DNA polymerase inhibitor | |||
| 0.11 | 0.032 | 0.11 | Alpha 2a adrenoreceptor antagonist | |||
| 0.174 | 0.097 | 0.174 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.147 | 0.071 | 0.147 | Thiol protease inhibitor | |||
| 0.152 | 0.076 | 0.304 | Diuretic | 0.287 0.025 CID_154699486 0.304 0.022 CID_154700038 | CID_154700038 | |
| 0.108 | 0.034 | 0.108 | Bile acid receptor antagonist | |||
| 0.136 | 0.062 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.111 | 0.039 | 0.111 | Androgen antagonist | |||
| 0.11 | 0.038 | 0.152 | Thioredoxin inhibitor | 0.152 0.016 CID_154699486 0.143 0.019 CID_154700038 | CID_154699486 | |
| 0.077 | 0.005 | 0.077 | Alpha 1d adrenoreceptor agonist | |||
| 0.086 | 0.015 | 0.086 | Phosphodiesterase 1C inhibitor | |||
| 0.258 | 0.187 | 0.258 | DNA polymerase beta inhibitor | |||
| 0.094 | 0.025 | 0.094 | Glycine receptor agonist | 0.088 0.03 CID_154699486 0.088 0.03 CID_154700038 | ||
| 0.147 | 0.077 | 0.151 | Phospholipase A2 inhibitor | 0.151 0.073 CID_154699486 0.125 0.109 CID_154700038 | CID_154699486 | |
| 0.089 | 0.019 | 0.089 | Androgen agonist | |||
| 0.102 | 0.033 | 0.102 | Myeloperoxidase inhibitor | |||
| 0.088 | 0.019 | 0.088 | Beta 3 adrenoreceptor antagonist | |||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.078 | 0.01 | 0.078 | Squalene epoxidase inhibitor | |||
| 0.091 | 0.023 | 0.091 | Bcl2 antagonist | |||
| 0.083 | 0.015 | 0.083 | Transcription factor RelA inhibitor | |||
| 0.087 | 0.02 | 0.087 | Alpha 2 adrenoreceptor agonist | |||
| 0.098 | 0.031 | 0.098 | Caspase 7 inhibitor | |||
| 0.074 | 0.008 | 0.074 | Liver X receptor alpha agonist | |||
| 0.117 | 0.05 | 0.117 | Protein kinase (CK2) inhibitor | |||
| 0.085 | 0.019 | 0.085 | Glutamate (mGluR6) antagonist | |||
| 0.152 | 0.086 | 0.152 | Growth hormone agonist | |||
| 0.078 | 0.013 | 0.078 | Bcl-xL inhibitor | |||
| 0.077 | 0.012 | 0.077 | Dihydroorotate oxidase inhibitor | |||
| 0.078 | 0.014 | 0.078 | Aconitate hydratase inhibitor | |||
| 0.093 | 0.029 | 0.093 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.079 | 0.016 | 0.079 | Sphingosine kinase 2 inhibitor | |||
| 0.07 | 0.007 | 0.07 | Geranyltranstransferase inhibitor | |||
| 0.115 | 0.053 | 0.115 | Alpha 2c adrenoreceptor antagonist | |||
| 0.103 | 0.041 | 0.103 | Ornithine decarboxylase inhibitor | 0.08 0.067 CID_154699486 | ||
| 0.097 | 0.035 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 CID_154699486 0.119 0.017 CID_154700038 | CID_154700038 | |
| 0.078 | 0.017 | 0.078 | Calcium channel P-type blocker | |||
| 0.099 | 0.037 | 0.099 | Adrenaline agonist | |||
| 0.065 | 0.004 | 0.065 | Estrogen-related receptor beta antagonist | |||
| 0.167 | 0.107 | 0.167 | MAP kinase kinase 2 inhibitor | |||
| 0.083 | 0.025 | 0.083 | Beta adrenoreceptor antagonist | |||
| 0.104 | 0.045 | 0.104 | Alpha 2 adrenoreceptor antagonist | |||
| 0.073 | 0.015 | 0.073 | DNA helicase inhibitor | 0.052 0.044 CID_154699486 0.052 0.044 CID_154700038 | ||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | |||
| 0.13 | 0.074 | 0.13 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.119 | 0.063 | 0.119 | Interleukin 1b antagonist | |||
| 0.114 | 0.058 | 0.114 | Acetylcholine release stimulant | 0.111 0.065 CID_154699486 0.111 0.065 CID_154700038 | ||
| 0.069 | 0.012 | 0.069 | Thymidylate synthase inhibitor | |||
| 0.076 | 0.019 | 0.076 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.077 | 0.022 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 CID_154699486 0.081 0.02 CID_154700038 | CID_154700038 | |
| 0.117 | 0.062 | 0.117 | TRPA1 agonist | |||
| 0.063 | 0.008 | 0.063 | Acid-sensing ion channel blocker | |||
| 0.082 | 0.028 | 0.082 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.111 | 0.058 | 0.111 | Aminopeptidase B inhibitor | |||
| 0.09 | 0.036 | 0.09 | Glutamate dehydrogenase inhibitor | |||
| 0.105 | 0.051 | 0.105 | MAP kinase kinase 1 inhibitor | |||
| 0.134 | 0.081 | 0.134 | Activin receptor-like kinase 2 inhibitor | |||
| 0.101 | 0.049 | 0.148 | Phosphodiesterase 6D inhibitor | 0.148 0.01 CID_154699486 0.148 0.01 CID_154700038 | CID_154700038 | |
| 0.065 | 0.015 | 0.091 | Glucose-6-phosphate isomerase inhibitor | 0.091 0.006 CID_154699486 0.091 0.006 CID_154700038 | CID_154700038 | |
| 0.131 | 0.081 | 0.131 | Farnesoid X receptor antagonist | |||
| 0.056 | 0.006 | 0.056 | Liver X receptor beta antagonist | |||
| 0.067 | 0.018 | 0.067 | Beta 2 adrenoreceptor antagonist | |||
| 0.072 | 0.023 | 0.072 | Sphingosine kinase inhibitor | |||
| 0.055 | 0.006 | 0.055 | ATP citrate lysase inhibitor | |||
| 0.107 | 0.059 | 0.181 | Toll-Like receptor 4 antagonist | 0.178 0.01 CID_154699486 0.181 0.009 CID_154700038 | CID_154700038 | |
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | |||
| 0.057 | 0.009 | 0.057 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.067 | 0.02 | 0.067 | Plasminogen activator inhibitor antagonist | |||
| 0.072 | 0.025 | 0.072 | Beta 1 adrenoreceptor antagonist | |||
| 0.162 | 0.115 | 0.785 | Angiogenesis stimulant | 0.776 0.004 CID_154699486 0.785 0.004 CID_154700038 | CID_154700038 | |
| 0.056 | 0.01 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.058 | 0.012 | 0.058 | Retinoid X alpha receptor agonist | |||
| 0.148 | 0.103 | 0.148 | Tumour necrosis factor antagonist | |||
| 0.061 | 0.016 | 0.061 | Dihydroorotase inhibitor | |||
| 0.062 | 0.016 | 0.062 | Adenylate cyclase 1 inhibitor | |||
| 0.049 | 0.004 | 0.049 | Alpha 2a adrenoreceptor agonist | |||
| 0.254 | 0.209 | 0.795 | Cyclophilin D inhibitor | 0.792 0.007 CID_154699486 0.795 0.007 CID_154700038 | CID_154700038 | |
| 0.08 | 0.035 | 0.08 | Phospholipase D inhibitor | |||
| 0.094 | 0.049 | 0.094 | Protein kinase A inhibitor | |||
| 0.055 | 0.013 | 0.055 | Nerve growth factor antagonist | |||
| 0.137 | 0.094 | 0.137 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.065 | 0.023 | 0.106 | Leukotriene B4 antagonist | 0.106 0.009 CID_154699486 0.103 0.01 CID_154700038 | CID_154699486 | |
| 0.057 | 0.015 | 0.057 | Retinoid X receptor agonist | |||
| 0.088 | 0.046 | 0.142 | Glycine receptor antagonist | 0.127 0.014 CID_154699486 0.142 0.009 CID_154700038 | CID_154700038 | |
| 0.07 | 0.028 | 0.07 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.063 | 0.021 | 0.117 | Glucose-6-phosphate translocase inhibitor | 0.115 0.005 CID_154699486 0.117 0.004 CID_154700038 | CID_154700038 | |
| 0.133 | 0.092 | 0.133 | Acetylcholine M1 receptor antagonist | |||
| 0.082 | 0.041 | 0.082 | Aminopeptidase I inhibitor | |||
| 0.072 | 0.032 | 0.072 | NMDA 2C receptor antagonist | |||
| 0.133 | 0.093 | 0.321 | Insulin secretagoues | 0.321 0.01 CID_154699486 0.306 0.012 CID_154700038 | CID_154699486 | |
| 0.058 | 0.018 | 0.058 | Dopamine beta hydroxylase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Biliverdin reductase inhibitor | |||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | |||
| 0.143 | 0.103 | 0.143 | Antipruritic | |||
| 0.067 | 0.029 | 0.067 | Carbonic anhydrase VB inhibitor | |||
| 0.098 | 0.061 | 0.098 | MAO B inhibitor | |||
| 0.066 | 0.029 | 0.066 | Beta 2 adrenoreceptor agonist | |||
| 0.076 | 0.039 | 0.076 | Elastase 1 inhibitor | |||
| 0.157 | 0.12 | 0.157 | Focal adhesion kinase 2 inhibitor | |||
| 0.073 | 0.037 | 0.073 | Exportin-1 inhibitor | |||
| 0.085 | 0.049 | 0.085 | CC chemokine 5 receptor agonist | |||
| 0.148 | 0.112 | 0.148 | Death-associated protein kinase 2 inhibitor | |||
| 0.077 | 0.042 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.076 | 0.042 | 0.076 | Prostaglandin-E synthase inhibitor | |||
| 0.042 | 0.008 | 0.042 | Liver X receptor alpha antagonist | |||
| 0.099 | 0.065 | 0.099 | Bronchodilator | |||
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | |||
| 0.073 | 0.04 | 0.073 | Protein kinase C alpha inhibitor | |||
| 0.072 | 0.041 | 0.406 | Selectin antagonist | 0.401 0.003 CID_154699486 0.406 0.003 CID_154700038 | CID_154700038 | |
| 0.057 | 0.027 | 0.057 | Vanilloid 2 antagonist | |||
| 0.062 | 0.032 | 0.062 | Ryanodine receptor antagonist | |||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.069 | 0.039 | 0.069 | Aryl hydrocarbon receptor antagonist | |||
| 0.132 | 0.102 | 0.132 | MAP kinase 3 inhibitor | |||
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | |||
| 0.064 | 0.036 | 0.064 | Plasminogen activator inhibitor | |||
| 0.048 | 0.02 | 0.048 | Urate transporter 1 inhibitor | |||
| 0.041 | 0.013 | 0.041 | Liver X receptor antagonist | |||
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR8) agonist | |||
| 0.058 | 0.032 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_154699486 0.076 0.011 CID_154700038 | CID_154699486 | |
| 0.071 | 0.045 | 0.071 | Alpha adrenoreceptor agonist | |||
| 0.057 | 0.031 | 0.112 | Alpha-mannosidase inhibitor | 0.112 0.005 CID_154699486 0.112 0.005 CID_154700038 | CID_154700038 | |
| 0.041 | 0.015 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 CID_154699486 0.033 0.03 CID_154700038 | ||
| 0.05 | 0.025 | 0.05 | NMDA receptor subunit 3B antagonist | |||
| 0.061 | 0.036 | 0.061 | Argininosuccinate synthase inhibitor | |||
| 0.066 | 0.041 | 0.12 | Neuraminidase (influenza) inhibitor | 0.107 0.014 CID_154699486 0.12 0.012 CID_154700038 | CID_154700038 | |
| 0.036 | 0.012 | 0.036 | NMDA 2D receptor antagonist | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.058 | 0.034 | 0.058 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.171 | 0.147 | 0.171 | Calpain inhibitor | |||
| 0.032 | 0.009 | 0.032 | Hedgehog signaling activator | |||
| 0.17 | 0.147 | 0.17 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.061 | 0.039 | 0.061 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.026 | 0.004 | 0.047 | Antibiotic Anthracycline-like | 0.047 0.002 CID_154699486 0.047 0.002 CID_154700038 | CID_154700038 | |
| 0.038 | 0.017 | 0.038 | Liver X receptor beta agonist | |||
| 0.057 | 0.036 | 0.057 | 5 Hydroxytryptamine 7 agonist | |||
| 0.052 | 0.03 | 0.094 | Factor III inhibitor | 0.094 0.005 CID_154699486 0.063 0.015 CID_154700038 | CID_154699486 | |
| 0.067 | 0.046 | 0.067 | Carbonic anhydrase V inhibitor | |||
| 0.042 | 0.021 | 0.042 | CF transmembrane conductance regulator antagonist | |||
| 0.044 | 0.024 | 0.044 | Sphingosine kinase 1 inhibitor | |||
| 0.042 | 0.021 | 0.042 | Progesterone antagonist | |||
| 0.049 | 0.029 | 0.049 | Benzodiazepine antagonist | |||
| 0.059 | 0.039 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.045 | 0.025 | 0.045 | Histone deacetylase 8 inhibitor | |||
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | |||
| 0.05 | 0.03 | 0.05 | Cholesterol esterase inhibitor | |||
| 0.07 | 0.051 | 0.07 | NMDA 2 receptor antagonist | |||
| 0.036 | 0.017 | 0.036 | Protein kinase (CK2) beta inhibitor | |||
| 0.101 | 0.083 | 0.101 | Nav1.5 sodium channel blocker | |||
| 0.068 | 0.049 | 0.068 | Carbonic anhydrase VA inhibitor | |||
| 0.055 | 0.037 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.088 | 0.07 | 0.088 | ABCA1 expression enhancer | |||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.035 | 0.017 | 0.035 | Cholesterol ester transfer protein antagonist | |||
| 0.094 | 0.077 | 0.094 | Falcipain 3 inhibitor | |||
| 0.033 | 0.017 | 0.033 | Purinergic P2Y14 antagonist | |||
| 0.099 | 0.083 | 0.099 | Anesthetic local | |||
| 0.052 | 0.036 | 0.052 | NMDA 2A receptor antagonist | |||
| 0.046 | 0.031 | 0.046 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.034 | 0.106 | Carbonic anhydrase XIV inhibitor | 0.106 0.009 CID_154699486 0.081 0.016 CID_154700038 | CID_154699486 | |
| 0.109 | 0.094 | 0.109 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.053 | 0.038 | 0.171 | Heparanase inhibitor | 0.171 0.002 CID_154699486 0.171 0.002 CID_154700038 | CID_154700038 | |
| 0.089 | 0.075 | 0.089 | Electrolyte absorption antagonist | |||
| 0.069 | 0.055 | 0.069 | Dopamine antagonist | |||
| 0.096 | 0.082 | 0.096 | GABA receptor agonist | |||
| 0.045 | 0.032 | 0.117 | Mannosidase inhibitor | 0.117 0.005 CID_154699486 0.117 0.005 CID_154700038 | CID_154700038 | |
| 0.028 | 0.016 | 0.113 | Sodium/glucose cotransporter 2 inhibitor | 0.109 0.003 CID_154699486 0.113 0.002 CID_154700038 | CID_154700038 | |
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.055 | 0.043 | 0.055 | Leukotriene C antagonist | |||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | |||
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR4) antagonist | |||
| 0.023 | 0.012 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.09 | 0.08 | 0.09 | Nav1.1 sodium channel blocker | |||
| 0.101 | 0.09 | 0.101 | Caspase 3 inhibitor | |||
| 0.078 | 0.068 | 0.078 | NMDA receptor antagonist | |||
| 0.041 | 0.032 | 0.051 | Guanylate cyclase inhibitor | 0.051 0.02 CID_154699486 0.051 0.02 CID_154700038 | CID_154700038 | |
| 0.041 | 0.031 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.067 | 0.058 | 0.067 | Cathepsin G inhibitor | |||
| 0.06 | 0.051 | 0.06 | Leukotriene antagonist | 0.057 0.055 CID_154699486 | ||
| 0.097 | 0.087 | 0.097 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.034 | 0.025 | 0.034 | Fumarate hydratase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Sirtuin 2 inhibitor | |||
| 0.025 | 0.017 | 0.042 | Vanilloid 2 agonist | 0.042 0.004 CID_154699486 0.042 0.004 CID_154700038 | CID_154700038 | |
| 0.073 | 0.065 | 0.092 | Interferon agonist | 0.092 0.036 CID_154699486 0.092 0.036 CID_154700038 | CID_154700038 | |
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.044 | 0.037 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.056 | 0.049 | 0.101 | Neuraminidase inhibitor | 0.09 0.019 CID_154699486 0.101 0.015 CID_154700038 | CID_154700038 | |
| 0.042 | 0.035 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.058 | 0.051 | 0.058 | Heme oxygenase stimulant | |||
| 0.026 | 0.02 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.02 | 0.014 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.043 | 0.037 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_154699486 0.066 0.009 CID_154700038 | CID_154700038 | |
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.033 | 0.027 | 0.033 | Phosphoglycerate kinase inhibitor | |||
| 0.035 | 0.03 | 0.035 | NMDA receptor subunit 3A antagonist | |||
| 0.031 | 0.026 | 0.031 | Melatonin 2 agonist | |||
| 0.018 | 0.013 | 0.018 | Retinoic acid receptor antagonist | |||
| 0.175 | 0.171 | 0.175 | Neuropeptide Y2 antagonist | |||
| 0.074 | 0.069 | 0.074 | Opioid kappa receptor antagonist | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | |||
| 0.033 | 0.029 | 0.033 | Opioid delta receptor agonist | |||
| 0.025 | 0.02 | 0.025 | Thyroid hormone agonist | |||
| 0.056 | 0.052 | 0.056 | Dopamine D2 antagonist | |||
| 0.01 | 0.006 | 0.01 | Progesterone receptor A antagonist | |||
| 0.024 | 0.021 | 0.098 | Sodium/glucose cotransporter inhibitor | 0.094 0.003 CID_154699486 0.098 0.003 CID_154700038 | CID_154700038 | |
| 0.007 | 0.004 | 0.007 | Insulin like growth factor 3 antagonist | |||
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.057 | 0.054 | 0.057 | I kappa B kinase 2 inhibitor | |||
| 0.041 | 0.038 | 0.041 | Heme oxygenase inhibitor | |||
| 0.136 | 0.133 | 0.136 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.104 | 0.101 | 0.104 | Cathepsin H inhibitor | |||
| 0.058 | 0.056 | 0.058 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.027 | 0.024 | 0.027 | Purinergic P2Y15 antagonist | |||
| 0.024 | 0.022 | 0.024 | Complement factor 1s inhibitor | |||
| 0.02 | 0.018 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 CID_154699486 0.025 0.012 CID_154700038 | CID_154700038 | |
| 0.016 | 0.014 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699486 0.023 0.005 CID_154700038 | CID_154700038 | |
| 0.095 | 0.094 | 0.095 | Proteasome inhibitor | |||
| 0.116 | 0.115 | 0.378 | Thrombolytic | 0.355 0.016 CID_154699486 0.378 0.013 CID_154700038 | CID_154700038 | |
| 0.03 | 0.029 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.055 | 0.054 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.04 CID_154699486 0.061 0.044 CID_154700038 | CID_154699486 | |
| 0.024 | 0.023 | 0.024 | Thymidine phosphorylase inhibitor | |||
| 0.017 | 0.016 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.133 | 0.132 | 0.133 | Interleukin antagonist | |||
| 0.095 | 0.096 | 0.125 | Beta amyloid protein antagonist | 0.125 0.062 CID_154699486 0.099 0.092 CID_154700038 | CID_154699486 | |
| 0.008 | 0.015 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699486 0.011 0.006 CID_154700038 | CID_154700038 | |
| 0.01 | 0.025 | 0.036 | Ileal bile acid transport inhibitor | 0.036 0.004 CID_154699486 0.03 0.005 CID_154700038 | CID_154699486 | |
| 0.034 | 0.051 | 0.092 | Carbonic anhydrase XII inhibitor | 0.092 0.022 CID_154699486 0.073 0.028 CID_154700038 | CID_154699486 | |
| 0.016 | 0.039 | 0.071 | Protein 30S ribosomal subunit inhibitor | 0.07 0.005 CID_154699486 0.071 0.005 CID_154700038 | CID_154700038 | |
| 0.052 | 0.077 | 0.065 | Interferon inducer | 0.065 0.044 CID_154699486 0.065 0.044 CID_154700038 | CID_154700038 | |
| 0.019 | 0.045 | 0.058 | Arginase inhibitor | 0.058 0.011 CID_154699486 0.048 0.016 CID_154700038 | CID_154699486 | |
| 0.12 | 0.147 | 0.151 | Psychostimulant | 0.151 0.115 CID_154699486 | CID_154699486 | |
| 0.029 | 0.061 | 0.055 | Carbonic anhydrase IX inhibitor | 0.055 0.039 CID_154699486 | CID_154699486 | |
| 0.023 | 0.08 | 0.075 | Phosphorylase inhibitor | 0.075 0.018 CID_154699486 0.062 0.024 CID_154700038 | CID_154699486 | |
| 0.162 | 0.222 | 0.244 | Angiogenesis inhibitor | 0.214 0.154 CID_154699486 0.244 0.127 CID_154700038 | CID_154700038 | |
| 0.144 | 0.211 | 0.414 | Peptidyltransferase inhibitor | 0.414 0.006 CID_154699486 0.404 0.007 CID_154700038 | CID_154699486 | |
| 0.093 | 0.189 | 0.422 | Platelet adhesion inhibitor | 0.421 0.01 CID_154699486 0.422 0.009 CID_154700038 | CID_154700038 | |
| 0.041 | 0.144 | 0.068 | Lipocortins synthesis agonist | 0.068 0.024 CID_154699486 0.067 0.025 CID_154700038 | CID_154699486 | |
| 0.012 | 0.127 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 CID_154699486 0.029 0.017 CID_154700038 | CID_154699486 | |
| 0.005 | 0.165 | 0.034 | Squalene synthetase inhibitor | 0.031 0.023 CID_154699486 0.034 0.021 CID_154700038 | CID_154700038 | |
| 0.062 | 0.233 | 0.296 | Cell adhesion inhibitor | 0.29 0.011 CID_154699486 0.296 0.01 CID_154700038 | CID_154700038 | |
| 0.078 | 0.262 | 0.294 | Hypolipemic | 0.267 0.06 CID_154699486 0.294 0.05 CID_154700038 | CID_154700038 | |
| 0.021 | 0.207 | 0.074 | Nitric oxide donor | 0.064 0.042 CID_154699486 0.074 0.028 CID_154700038 | CID_154700038 | |
| 0.075 | 0.281 | 0.346 | Platelet antagonist | 0.311 0.049 CID_154699486 0.346 0.039 CID_154700038 | CID_154700038 | |
| 0.016 | 0.223 | 0.115 | Protein 50S ribosomal subunit inhibitor | 0.112 0.01 CID_154699486 0.115 0.01 CID_154700038 | CID_154700038 | |
| 0.017 | 0.228 | 0.083 | Antibiotic Aminoglycoside-like | 0.083 0.004 CID_154699486 0.083 0.004 CID_154700038 | CID_154700038 | |
| 0.014 | 0.265 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_154699486 0.046 0.034 CID_154700038 | CID_154700038 | |
| 0.122 | 0.385 | 0.425 | Interleukin 2 agonist | 0.425 0.021 CID_154699486 0.425 0.021 CID_154700038 | CID_154700038 | |
| 0.025 | 0.289 | 0.098 | Histone deacetylase SIRT1 stimulant | 0.098 0.029 CID_154699486 0.081 0.043 CID_154700038 | CID_154699486 | |
| 0.025 | 0.289 | 0.098 | Histone deacetylase stimulant | 0.098 0.029 CID_154699486 0.081 0.043 CID_154700038 | CID_154699486 | |
| 0.031 | 0.331 | 0.143 | Cell adhesion molecule inhibitor | 0.143 0.017 CID_154699486 0.143 0.017 CID_154700038 | CID_154700038 | |
| 0.041 | 0.346 | 0.153 | Transcription factor NF kappa B stimulant | 0.143 0.017 CID_154699486 0.153 0.015 CID_154700038 | CID_154700038 | |
| 0.015 | 0.321 | 0.063 | DNA gyrase inhibitor | 0.063 0.045 CID_154699486 | CID_154699486 | |
| 0.001 | 0.308 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_154699486 0.012 0.011 CID_154700038 | CID_154699486 | |
| 0.013 | 0.342 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.007 CID_154699486 0.034 0.007 CID_154700038 | CID_154700038 | |
| 0.019 | 0.374 | 0.092 | Factor IXa inhibitor | 0.092 0.012 CID_154699486 0.092 0.012 CID_154700038 | CID_154700038 | |
| 0.044 | 0.406 | 0.116 | Interleukin 12 antagonist | 0.108 0.042 CID_154699486 0.116 0.033 CID_154700038 | CID_154700038 | |
| 0.025 | 0.417 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.069 CID_154699486 | CID_154699486 | |
| 0.026 | 0.474 | 0.256 | Anticoagulant | 0.222 0.046 CID_154699486 0.256 0.037 CID_154700038 | CID_154700038 | |
| 0.041 | 0.635 | 0.409 | Immunomodulator | 0.351 0.059 CID_154699486 0.409 0.041 CID_154700038 | CID_154700038 | |
| 0.024 | 0.714 | 0.216 | Toll-Like receptor agonist | 0.216 0.182 CID_154700038 | CID_154700038 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |